Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06567041
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Investigation of the Safety Tolerability Pharmacokinetics and Efficacy of Subcutaneous Weekly Doses of NNC0519-0130 in Participants With Obesity and in Participants With Type 2 Diabetes With Either Overweight or Obesity
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A new study medicine called NNC0519-0130 to improve treatment options for people living with excess body weight with or without type 2 diabetes The purpose of the study is to investigate potential side effects and blood levels of NNC0519-0130 as well as changes in body weight blood sugar levels and heart activity The study consists of two groups with participants receiving either the study medicine NNC0519-0130 or a placebo Which treatment participants get is decided by chance and they can only participate in one group Participants will be given the study medicine once weekly and it should be taken on the same day each week The treatment duration depends on the group participants are enrolled in with the study lasting for 37 weeks for Group 1 and 34 weeks for Group 2
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None